BAKER BROS. ADVISORS LP Q1 2023 Filing
Filed May 15, 2023
Portfolio Value
$18.4B
Holdings
105
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (105 positions)
| Stock | Value |
|---|---|
SGENUSDSeagen Inc. | $9.5B |
INCYIncyte Corporation | $2.6B |
ONCBeiGene, Ltd. | $2.5B |
ACADACADIA Pharmaceuticals Inc. | $789.3M |
MDGLMadrigal Pharmaceuticals, Inc. | $374.3M |
BMRNBioMarin Pharmaceutical Inc. | $370.5M |
IMCRImmunocore Holdings plc | $124.6M |
RYTMRhythm Pharmaceuticals, Inc. | $115.9M |
KODKodiak Sciences Inc. | $107.3M |
BCRXBioCryst Pharmaceuticals, Inc. | $106.0M |
ARGXargenx SE | $104.4M |
AKROAkero Therapeutics, Inc. | $90.6M |
KYMRKymera Therapeutics, Inc. | $85.3M |
REPLReplimune Group, Inc. | $80.9M |
ABCLAbCellera Biologics Inc. | $78.8M |
SWTXSpringWorks Therapeutics, Inc. | $70.9M |
TRDAEntrada Therapeutics, Inc. | $70.6M |
BMEABiomea Fusion, Inc. | $65.4M |
RVMDRevolution Medicines, Inc. | $58.3M |
PRLDPrelude Therapeutics Inc. | $57.7M |
MRTXEURMirati Therapeutics, Inc. | $52.4M |
FGENEURFibroGen, Inc. | $49.2M |
CERSCerus Corporation | $47.7M |
1K0IGM Biosciences, Inc. | $43.4M |
AVTEAerovate Therapeutics, Inc. | $39.6M |
IMTXImmatics N.V. | $35.8M |
ROIVRoivant Sciences Ltd. | $35.3M |
NRIXNurix Therapeutics, Inc. | $34.5M |
290AChinook Therapeutics, Inc. | $33.7M |
KNSAKiniksa Pharmaceuticals, Ltd. | $30.1M |
—DICE Therapeutics, Inc. | $29.7M |
XENEXenon Pharmaceuticals Inc. | $26.9M |
TSVT*2seventy bio, Inc. | $25.5M |
DNLIDenali Therapeutics Inc. | $25.1M |
—DBV Technologies S.A. | $24.7M |
KRYSKrystal Biotech, Inc. | $24.2M |
VERVVerve Therapeutics, Inc. | $20.4M |
RAREUltragenyx Pharmaceutical Inc. | $18.9M |
BCYCBicycle Therapeutics plc | $17.9M |
STOKStoke Therapeutics, Inc. | $17.6M |
ANABAnaptysBio, Inc. | $16.9M |
RNAAvidity Biosciences, Inc. | $15.4M |
2L9Blueprint Medicines Corporation | $15.0M |
SPRYARS Pharmaceuticals, Inc. | $13.1M |
PACBPacific Biosciences of California, Inc. | $13.1M |
PRMEPrime Medicine, Inc. | $12.7M |
HRTXHeron Therapeutics, Inc. | $12.3M |
NVTA1EURInvitae Corporation | $12.0M |
IDYAIDEAYA Biosciences, Inc. | $11.4M |
CABACabaletta Bio, Inc. | $11.1M |
SMMTSummit Therapeutics Inc. | $11.0M |
ADAPYAdaptimmune Therapeutics plc | $10.7M |
OPTEYOpthea Limited | $10.6M |
VSTMVerastem, Inc. | $10.6M |
FATEFate Therapeutics, Inc. | $9.5M |
—POINT Biopharma Global Inc. | $8.5M |
—bluebird bio, Inc. | $7.9M |
ALLOAllogene Therapeutics, Inc. | $7.8M |
—Mersana Therapeutics, Inc. | $7.8M |
WHWKAadi Bioscience, Inc. | $7.2M |
SERASera Prognostics, Inc. | $6.9M |
GONGeron Corporation | $6.6M |
SANASana Biotechnology, Inc. | $6.5M |
VSAREURAravive, Inc. | $6.5M |
MGNXMacroGenics, Inc. | $6.4M |
ALECAlector, Inc. | $6.0M |
—Athira Pharma, Inc. | $5.9M |
TCRXTScan Therapeutics, Inc. | $5.8M |
IM8NInsmed Incorporated | $5.8M |
NTRANatera, Inc. | $5.6M |
CMPXCompass Therapeutics, Inc. | $5.1M |
—Affimed N.V. | $4.9M |
RLAYRelay Therapeutics, Inc. | $4.7M |
BCELAtreca, Inc. | $4.0M |
IPSCCentury Therapeutics, Inc. | $4.0M |
—Talis Biomedical Corporation | $3.7M |
DSGNDesign Therapeutics, Inc. | $3.6M |
TILInstil Bio, Inc. | $3.5M |
XNCRXencor, Inc. | $3.4M |
VORVor Biopharma Inc. | $3.4M |
EWTXEdgewise Therapeutics, Inc. | $3.3M |
TNGXTango Therapeutics, Inc. | $3.0M |
GLUEMonte Rosa Therapeutics, Inc. | $2.9M |
—Neoleukin Therapeutics, Inc. | $2.7M |
VERAVera Therapeutics, Inc. | $2.6M |
HOOKGBPHOOKIPA Pharma Inc. | $2.6M |
LPTXEURLeap Therapeutics, Inc. | $2.5M |
698Achilles Therapeutics plc | $2.5M |
ATRAGBXAtara Biotherapeutics, Inc. | $2.2M |
5E7iTeos Therapeutics, Inc. | $2.0M |
VERUEURVeru Inc. | $1.9M |
PCVXVaxcyte, Inc. | $1.8M |
ALGSAligos Therapeutics, Inc. | $1.8M |
PMVPPMV Pharmaceuticals, Inc. | $1.5M |
PRAXPraxis Precision Medicines, Inc. | $1.5M |
NKTXNkarta, Inc. | $1.4M |
KALAKala Pharmaceuticals, Inc. | $1.2M |
—TCR2 Therapeutics Inc. | $1.1M |
AGLEUSDAeglea BioTherapeutics, Inc. | $988K |
TARAProtara Therapeutics, Inc. | $624K |
Page 1 of 2Next